Table 3. Correlation analyses among serum uric acid levels and clinical characteristics in subjects with type 2 diabetes mellitus.
| Variable |
All subjects |
eGFR normal |
eGFR abnormal |
|||
|---|---|---|---|---|---|---|
| rs | P | rs | P | rs | P | |
| Age (years) | −0.014 | 0.538 | −0.119 | 0.000 | −0.092 | 0.008 |
| BMI (kg/m2) | 0.257 | 0.000 | 0.297 | 0.000 | 0.228 | 0.000 |
| SBP (mmHg) | 0.159 | 0.000 | 0.105 | 0.001 | 0.084 | 0.021 |
| DBP (mmHg) | 0.092 | 0.000 | 0.068 | 0.030 | 0.109 | 0.003 |
| ALT (IU/l) | 0.089 | 0.000 | 0.178 | 0.000 | 0.091 | 0.029 |
| AST (IU/l) | 0.179 | 0.000 | 0.199 | 0.000 | 0.172 | 0.000 |
| GGT (IU/l) | 0.190 | 0.000 | 0.281 | 0.000 | 0.131 | 0.002 |
| BUN (mmol/l) | 0.296 | 0.000 | 0.132 | 0.000 | 0.357 | 0.000 |
| SCR (μmol/l) | 0.410 | 0.000 | 0.361 | 0.000 | 0.373 | 0.000 |
| eGFR (ml/min per 1.73 m2) | −0.270 | 0.000 | −0.122 | 0.000 | −0.247 | 0.000 |
| TG (mmol/l) | 0.266 | 0.000 | 0.309 | 0.000 | 0.213 | 0.000 |
| TC (mmol/l) | 0.014 | 0.540 | 0.011 | 0.709 | −0.033 | 0.344 |
| HDL (mmol/l) | −0.155 | 0.000 | −0.184 | 0.000 | −0.155 | 0.000 |
| LDL (mmol/l) | 0.007 | 0.784 | −0.006 | 0.847 | −0.051 | 0.242 |
| VLDL (mmol/l) | 0.217 | 0.000 | 0.271 | 0.000 | 0.118 | 0.005 |
| HbA1c (%) | −0.109 | 0.000 | −0.115 | 0.000 | −0.036 | 0.320 |
| FPG (mmol/l) | −0.035 | 0.135 | −0.018 | 0.576 | −0.022 | 0.556 |
| P2hG (mmol/l) | −0.178 | 0.000 | −0.221 | 0.000 | −0.140 | 0.092 |
| FINS (mIU/l) | 0.225 | 0.000 | 0.218 | 0.000 | 0.219 | 0.010 |
| P2INS (mIU/l) | 0.206 | 0.000 | 0.207 | 0.000 | 0.170 | 0.052 |
| HOMA-IR | 0.190 | 0.000 | 0.177 | 0.000 | 0.187 | 0.031 |
| duration of diabetes (years) | 0.058 | 0.009 | 0.047 | 0.010 | 0.026 | 0.447 |
Abbreviations are as in Table 1.